Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Clover Health Investments Q3 2026 Results: Turns Profitable, Net Income $6.43M

Clover Health Investments, Corp. is a remote-first healthcare technology company that operates as a large accelerated filer. As of October 30, 2026, the company had 439,707,261 shares of Class A and 95,713,497 shares of Class B common stock outstanding. The filing highlights the expansion of its Clover Assistant technology under the brand name Counterpart Assistant for external payors and providers.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue759.3496.6
Net income6.4-24.4
EPS (diluted, $ a share)$0.01$-0.05

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Revenue, year on year+52.9%
Operating margin0.8%
Source

10-Q filed with the SEC, NASDAQ: CLOV. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Clover Health Investments, Corp.: key numbers

Share price
$4.73Close, Nov 17
Sector
Finance
Industry
Hospital & Medical Service PlansSIC 6324

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Clover Health Investments, Corp.

All →
6:35 PM ET 8-K
Business Update

Clover Health Investments Business Update

Clover Health published a supplemental Q&A document to address frequently asked shareholder questions following its third quarter 2026 earnings announcement. The update discusses long-term projections through 2028, membership cohort maturation, and plans to improve the company's Adjusted SG&A ratio through operating leverage as it scales.

4:08 PM ET 8-K
Financial Results

Clover Health Investments Financial Results

Clover Health reported Q3 2026 financial results, achieving GAAP net income of $6 million and total revenue growth of 53% year-over-year to $759.3 million. The company raised its full-year 2026 guidance, now expecting total revenues between $2.97 billion and $3.00 billion and its first full year of GAAP net income profitability. Alongside the results, the company appointed Interim CFO Joseph Clay Thornton to the role on a permanent basis.

Term
Q3 2026

“Our results further demonstrate our technology-powered differentiation, and how earlier and better care management, market-leading growth, and increasing profitability can reinforce one another under the right model.”

Andrew Toy, Clover Health CEO

“In 2026, Clover is on track to have grown significantly and expects to deliver its first full year of GAAP Net Income profitability. With our largest member cohorts maturing, continued operating leverage, and strong Star ratings performance, we believe we are well positioned for meaningful earnings expansion in 2027.”

Clay Thornton, Clover Health CFO
5:57 PM ET Form 4
Insider Selling

Clover Health Investments CLO Karen Soares Sells $89.8K of Stock

Karen Soares, CLO, sold 19,275 shares of Clover Health Investments, Corp. at $4.66 a share, worth $89.8K in total on Oct 20, 2026. Shares held after the trade: 1,573,423 (-1.2%).

Value
$89.8K
Shares
19,275
Price
$4.66
Role
CLO
Holding change
-1.2%
Trade date
Oct 20, 2026
4:43 PM ET Form 4
Insider Selling

Clover Health Investments CEO, Medicare Advantage Jamie L. Reynoso Sells $17.9K of Stock

Jamie L. Reynoso, CEO, Medicare Advantage, sold 4,066 shares of Clover Health Investments, Corp. at $4.41 a share, worth $17.9K in total on Oct 19, 2026. Shares held after the trade: 2,770,351 (-0.1%).

Value
$17.9K
Shares
4,066
Price
$4.41
Role
CEO, Medicare Advantage
Holding change
-0.1%
Trade date
Oct 19, 2026
4:31 PM ET Form 4
Insider Selling

Clover Health Investments CEO Andrew Toy Sells $291K of Stock

Andrew Toy, CEO, sold 62,176 shares of Clover Health Investments, Corp. at $4.68 a share, worth $291K in total on Oct 15, 2026. Shares held after the trade: 9,078,334 (-0.7%).

Value
$291K
Shares
62,176
Price
$4.68
Role
CEO
Holding change
-0.7%
Trade date
Oct 15, 2026
4:26 PM ET Form 4
Insider Selling

Clover Health Investments CLO Karen Soares Sells $68.7K of Stock

Karen Soares, CLO, sold 14,673 shares of Clover Health Investments, Corp. at $4.68 a share, worth $68.7K in total on Oct 15, 2026. Shares held after the trade: 1,592,698 (-0.9%).

Value
$68.7K
Shares
14,673
Price
$4.68
Role
CLO
Holding change
-0.9%
Trade date
Oct 15, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.